Fertility preservation during treatment is a growing issue for women.
Rowan
Karen
K
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D015925:Cryopreservation; D026690:Ethics, Clinical; D005260:Female; D005300:Fertility Agents, Female / Q000494:pharmacology; D006801:Humans; D007247:Infertility, Female / Q000139:chemically induced / Q000209:etiology* / Q000517:prevention & control*; D016729:Leuprolide / Q000494:pharmacology; D008495:Medical Oncology / Q000941:ethics / Q000379:methods / Q000592:standards*; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D009865:Oocytes; D017410:Practice Guidelines as Topic; D016649:Primary Ovarian Insufficiency / Q000139:chemically induced / Q000209:etiology* / Q000517:prevention & control*; D012955:Societies, Medical; D014182:Transplantation, Autologous; D014481:United States; D055815:Young Adult
D000970:Antineoplastic Agents; D005300:Fertility Agents, Female; D016729:Leuprolide